dear all,

Here are my comments which I did yesterday, so it's on the previous version, but I've quickly made a few similar comments in the new version. Both are attached.
It's only to shift in nuance here and there, an attempt to avoid potential confusion (regarding our campaign to keep new GM regulated; and industry's attempt to equate random mutagenesis and genome editing). Just see if it works.

my two cents,

Nina

Dear all,


please see attached new draft versions of the PR for Thursday. I would
need final comments till Monday evening, if possible.

thanks to te good suggestions from Katherine and Daniela (FOE Germany) I
found a way to shorten it and two include two quotes.

After having read the proposals made by Katherine, I think it is
important to not have to many details in the PR. We might draft a letter
to the EPO where we can include further details, but anyway they are in
the report.

So I used mostly used the the more simplified version of Daniela. Hope
everybody can agree. You also can use the draft for preparing your own
PR, but I guess most of yow will wait for the Enlarged Board of Appeal.

Short notice: I again asked the EPO and they again responded that they
do not know the date. But we will get informed (we still have to prepare
a PR in two versions for that day).

I will approach the German media agency (dpa) if they are interested to
get the report before hand.


Cheers


Christoph

_______________________________________________
Npos_2018 mailing list
Npos_2018@testbiotech.de
https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018